{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:14:13Z","timestamp":1785842053893,"version":"3.56.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T00:00:00Z","timestamp":1291075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T00:00:00Z","timestamp":1291075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12672-010-0054-2","type":"journal-article","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T14:53:16Z","timestamp":1291042396000},"page":"277-290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Microenvironment and Pathogenesis of Epithelial Ovarian Cancer"],"prefix":"10.1007","volume":"1","author":[{"given":"Antonio F.","family":"Saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,30]]},"reference":[{"key":"54_CR1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277\u2013300.","DOI":"10.3322\/caac.20073"},{"issue":"6","key":"54_CR2","first-page":"921","volume":"74","author":"PP Koonings","year":"1989","unstructured":"Koonings PP, Campbell K, Mishell DR Jr, Grimes DA (1989) Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 74(6):921\u2013926.","journal-title":"Obstet Gynecol"},{"issue":"21","key":"54_CR3","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van\u2019t Veer L, Garber JE, Evans G et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616\u20131622. doi:10.1056\/NEJMoa012158","journal-title":"N Engl J Med"},{"issue":"22","key":"54_CR4","doi-asserted-by":"publisher","first-page":"10602","DOI":"10.1158\/0008-5472.CAN-05-2240","volume":"65","author":"T Bonome","year":"2005","unstructured":"Bonome T, Lee JY, Park DC, Radonovich M, Pise-Masison C, Brady J, Gardner GJ et al (2005) Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res 65(22):10602\u201310612","journal-title":"Cancer Res"},{"issue":"2","key":"54_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/er.22.2.255","volume":"22","author":"N Auersperg","year":"2001","unstructured":"Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22(2):255\u2013288","journal-title":"Endocr Rev"},{"issue":"8","key":"54_CR6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4161\/cc.4.8.1906","volume":"4","author":"H Naora","year":"2005","unstructured":"Naora H (2005) Developmental patterning in the wrong context: the paradox of epithelial ovarian cancers. Cell Cycle 4(8):1033\u20131035","journal-title":"Cell Cycle"},{"issue":"7716","key":"54_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF (1971) Incessant ovulation\u2014a factor in ovarian neoplasia? Lancet 2(7716):163","journal-title":"Lancet"},{"issue":"10","key":"54_CR8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","volume":"136","author":"AS Whittemore","year":"1992","unstructured":"Whittemore AS, Harris R, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case\u2013control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136(10):1184\u20131203","journal-title":"Am J Epidemiol"},{"issue":"7","key":"54_CR9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/oxfordjournals.aje.a117296","volume":"140","author":"HA Risch","year":"1994","unstructured":"Risch HA, Marrett LD, Howe GR (1994) Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 140(7):585\u2013597","journal-title":"Am J Epidemiol"},{"issue":"4","key":"54_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/aje\/kwf048","volume":"156","author":"T Riman","year":"2002","unstructured":"Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR (2002) Risk factors for invasive epithelial ovarian cancer: results from a Swedish case\u2013control study. Am J Epidemiol 156(4):363\u2013373","journal-title":"Am J Epidemiol"},{"issue":"6","key":"54_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0895-4356(90)90160-Q","volume":"43","author":"ML Gwinn","year":"1990","unstructured":"Gwinn ML, Lee NC, Rhodes PH, Layde PM, Rubin GL (1990) Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 43(6):559\u2013568","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"54_CR12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/oxfordjournals.aje.a113791","volume":"119","author":"PC Nasca","year":"1984","unstructured":"Nasca PC, Greenwald P, Chorost S, Richart R, Caputo T (1984) An epidemiologic case\u2013control study of ovarian cancer and reproductive factors. Am J Epidemiol 119(5):705\u2013713","journal-title":"Am J Epidemiol"},{"key":"54_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2307\/3430596","volume":"73","author":"TN Fredrickson","year":"1987","unstructured":"Fredrickson TN (1987) Ovarian tumors of the hen. Environ Health Perspect 73:35\u201351","journal-title":"Environ Health Perspect"},{"issue":"2","key":"54_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0950-3552(05)80140-3","volume":"7","author":"JA Land","year":"1993","unstructured":"Land JA (1993) Ovulation, ovulation induction and ovarian carcinoma. Bailli\u00e8res Clin Obstet Gynaecol 7(2):455\u2013472","journal-title":"Bailli\u00e8res Clin Obstet Gynaecol"},{"issue":"23","key":"54_CR15","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","volume":"90","author":"HA Risch","year":"1998","unstructured":"Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90(23):1774\u20131786","journal-title":"J Natl Cancer Inst"},{"issue":"4 Pt 1","key":"54_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/0029-7844(96)00226-8","volume":"88","author":"JM Schildkraut","year":"1996","unstructured":"Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C (1996) Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 88(4 Pt 1):554\u2013559","journal-title":"Obstet Gynecol"},{"issue":"5","key":"54_CR17","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1210\/jc.87.5.2245","volume":"87","author":"KC Choi","year":"2002","unstructured":"Choi KC, Kang SK, Tai CJ, Auersperg N, Leung PC (2002) Follicle-stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells. J Clin Endocrinol Metab 87(5):2245\u20132253","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"54_CR18","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1210\/en.2009-1318","volume":"151","author":"MT Lau","year":"2010","unstructured":"Lau MT, Wong AS, Leung PC (2010) Gonadotropins induce tumor cell migration and invasion by increasing cyclooxygenases expression and prostaglandin E(2) production in human ovarian cancer cells. Endocrinology 151(7):2985\u20132993. doi:10.1210\/en.2009-1318","journal-title":"Endocrinology"},{"issue":"11","key":"54_CR19","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1210\/jc.2004-0044","volume":"89","author":"JH Choi","year":"2004","unstructured":"Choi JH, Choi KC, Auersperg N, Leung PC (2004) Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells. J Clin Endocrinol Metab 89(11):5508\u20135516","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"54_CR20","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1349-7006.2003.tb01384.x","volume":"94","author":"H Tashiro","year":"2003","unstructured":"Tashiro H, Katabuchi H, Begum M, Li X, Nitta M, Ohtake H, Okamura H (2003) Roles of luteinizing hormone\/chorionic gonadotropin receptor in anchorage-dependent and -independent growth in human ovarian surface epithelial cell lines. Cancer Sci 94(11):953\u2013959","journal-title":"Cancer Sci"},{"issue":"5","key":"54_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/ijc.20478","volume":"112","author":"Q Ji","year":"2004","unstructured":"Ji Q, Liu PI, Chen PK, Aoyama C (2004) Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells. Int J Cancer 112(5):803\u2013814","journal-title":"Int J Cancer"},{"issue":"6","key":"54_CR22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/01.AOG.0000128139.92313.74","volume":"103","author":"LA Brinton","year":"2004","unstructured":"Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL (2004) Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 103(6):1194\u20131203","journal-title":"Obstet Gynecol"},{"issue":"17","key":"54_CR23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","volume":"91","author":"RB Ness","year":"1999","unstructured":"Ness RB, Cottreau C (1999) Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91(17):1459\u20131467","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"54_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1006\/gyno.1999.5628","volume":"76","author":"W Zheng","year":"2000","unstructured":"Zheng W, Lu JJ, Luo F, Zheng Y, Feng Y, Felix JC, Lauchlan SC, Pike MC (2000) Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol Oncol 76(1):80\u201388","journal-title":"Gynecol Oncol"},{"issue":"24","key":"54_CR25","doi-asserted-by":"publisher","first-page":"13203","DOI":"10.1073\/pnas.94.24.13203","volume":"94","author":"YS Schiffenbauer","year":"1997","unstructured":"Schiffenbauer YS, Abramovitch R, Meir G, Nevo N, Holzinger M, Itin A, Keshet E, Neeman M (1997) Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 94(24):13203\u201313208","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"54_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ijc.1593","volume":"97","author":"J Wang","year":"2002","unstructured":"Wang J, Luo F, Lu JJ, Chen PK, Liu P, Zheng W (2002) VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors. Int J Cancer 97(2):163\u2013167","journal-title":"Int J Cancer"},{"issue":"2","key":"54_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/gyno.2001.6512","volume":"84","author":"YS Schiffenbauer","year":"2002","unstructured":"Schiffenbauer YS, Meir G, Maoz M, Even-Ram SC, Bar-Shavit R, Neeman M (2002) Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin. Gynecol Oncol 84(2):296\u2013302","journal-title":"Gynecol Oncol"},{"issue":"7","key":"54_CR28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/oxfordjournals.aje.a117055","volume":"139","author":"L Rosenberg","year":"1994","unstructured":"Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Lewis JL Jr, Strom BL, Harlap S, Shapiro S (1994) A case\u2013control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 139(7):654\u2013661","journal-title":"Am J Epidemiol"},{"issue":"6","key":"54_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0010-7824(83)90023-9","volume":"27","author":"UJ Gaspard","year":"1983","unstructured":"Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P (1983) Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel. Contraception 27(6):577\u2013590","journal-title":"Contraception"},{"issue":"6","key":"54_CR30","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/sj.bjc.6600154","volume":"86","author":"RJ Edmondson","year":"2002","unstructured":"Edmondson RJ, Monaghan JM, Davies BR (2002) The human ovarian surface epithelium is an androgen responsive tissue. Br J Cancer 86(6):879\u2013885","journal-title":"Br J Cancer"},{"issue":"6","key":"54_CR31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1210\/jcem-49-6-851","volume":"49","author":"KP McNatty","year":"1979","unstructured":"McNatty KP, Smith DM, Makris A, Osathanondh R, Ryan KJ (1979) The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 49(6):851\u2013860","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"54_CR32","first-page":"139","volume":"27","author":"H Seeger","year":"2006","unstructured":"Seeger H, Wallwiener D, Mueck AO (2006) Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors? Eur J Gynaecol Oncol 27(2):139\u2013141","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"54_CR33","first-page":"239","volume":"51","author":"MA Altinoz","year":"2004","unstructured":"Altinoz MA, Korkmaz R (2004) NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma 51(4):239\u2013247","journal-title":"Neoplasma"},{"issue":"5","key":"54_CR34","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0002-9378(96)70597-5","volume":"174","author":"DS Heller","year":"1996","unstructured":"Heller DS, Westhoff C, Gordon RE, Katz N (1996) The relationship between perineal cosmetic talc usage and ovarian talc particle burden. Am J Obstet Gynecol 174(5):1507\u20131510","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"54_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00001622-199809000-00012","volume":"10","author":"BD Duggan","year":"1998","unstructured":"Duggan BD, Dubeau L (1998) Genetics and biology of gynecologic cancer. Curr Opin Oncol 10(5):439\u2013446","journal-title":"Curr Opin Oncol"},{"issue":"15","key":"54_CR36","first-page":"5895","volume":"61","author":"V Shridhar","year":"2001","unstructured":"Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M et al (2001) Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res 61(15):5895\u20135904","journal-title":"Cancer Res"},{"issue":"5","key":"54_CR37","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1111\/j.1525-1438.2006.00660.x","volume":"16","author":"JM Lancaster","year":"2006","unstructured":"Lancaster JM, Dressman HK, Clarke JP, Sayer RA, Martino MA, Cragun JM, Henriott AH et al (2006) Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. Int J Gynecol Cancer 16(5):1733\u20131745","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"54_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2005.05.003","volume":"57","author":"M Palma","year":"2006","unstructured":"Palma M, Ristori E, Ricevuto E, Giannini G, Gulino A (2006) BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers. Crit Rev Oncol Hematol 57(1):1\u201323. doi:10.1016\/j.critrevonc.2005.05.003","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"54_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/00016340500324621","volume":"85","author":"M Sogaard","year":"2006","unstructured":"Sogaard M, Kjaer SK, Gayther S (2006) Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention. Acta Obstet Gynecol Scand 85(1):93\u2013105","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"54_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","volume":"108","author":"AR Venkitaraman","year":"2002","unstructured":"Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108(2):171\u2013182","journal-title":"Cell"},{"issue":"11","key":"54_CR41","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","volume":"95","author":"K Yoshida","year":"2004","unstructured":"Yoshida K, Miki Y (2004) Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci 95(11):866\u2013871","journal-title":"Cancer Sci"},{"issue":"Pt 5","key":"54_CR42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/BST0340633","volume":"34","author":"SJ Boulton","year":"2006","unstructured":"Boulton SJ (2006) Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans 34(Pt 5):633\u2013645","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"54_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jcp.10257","volume":"196","author":"EM Rosen","year":"2003","unstructured":"Rosen EM, Fan S, Pestell RG, Goldberg ID (2003) BRCA1 gene in breast cancer. J Cell Physiol 196(1):19\u201341","journal-title":"J Cell Physiol"},{"issue":"9","key":"54_CR44","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/cncr.11310","volume":"97","author":"I Cass","year":"2003","unstructured":"Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY (2003) Improved survival in women with BRCA-associated ovarian carcinoma. Cancer 97(9):2187\u20132195","journal-title":"Cancer"},{"issue":"13","key":"54_CR45","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jnci\/94.13.990","volume":"94","author":"AA Jazaeri","year":"2002","unstructured":"Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET (2002) Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst 94(13):990\u20131000","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"54_CR46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ng0495-439","volume":"9","author":"SD Merajver","year":"1995","unstructured":"Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS (1995) Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet 9(4):439\u2013443. doi:10.1038\/ng0495-439","journal-title":"Nat Genet"},{"issue":"3","key":"54_CR47","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ygyno.2005.02.022","volume":"97","author":"WH Gotlieb","year":"2005","unstructured":"Gotlieb WH, Chetrit A, Menczer J, Hirsh-Yechezkel G, Lubin F, Friedman E, Modan B, Ben-Baruch G (2005) Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 97(3):780\u2013783","journal-title":"Gynecol Oncol"},{"issue":"19","key":"54_CR48","first-page":"5329","volume":"60","author":"RL Baldwin","year":"2000","unstructured":"Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY (2000) BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 60(19):5329\u20135333","journal-title":"Cancer Res"},{"issue":"7","key":"54_CR49","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","volume":"92","author":"M Esteller","year":"2000","unstructured":"Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E et al (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92(7):564\u2013569","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"54_CR50","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jnci\/94.18.1396","volume":"94","author":"JL Hilton","year":"2002","unstructured":"Hilton JL, Geisler JP, Rathe JA, Hattermann-Zogg MA, DeYoung B, Buller RE (2002) Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst 94(18):1396\u20131406","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"54_CR51","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","volume":"81","author":"M Aarnio","year":"1999","unstructured":"Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomaki P, Mecklin JP, Jarvinen HJ (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214\u2013218","journal-title":"Int J Cancer"},{"issue":"1","key":"54_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1535-6108(01)00002-2","volume":"1","author":"S Orsulic","year":"2002","unstructured":"Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind JS, Varmus HE (2002) Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 1(1):53\u201362","journal-title":"Cancer Cell"},{"issue":"6","key":"54_CR53","first-page":"1389","volume":"63","author":"DC Connolly","year":"2003","unstructured":"Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, Hamilton TC (2003) Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63(6):1389\u20131397","journal-title":"Cancer Res"},{"issue":"1","key":"54_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nm1173","volume":"11","author":"DM Dinulescu","year":"2005","unstructured":"Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11(1):63\u201370","journal-title":"Nat Med"},{"issue":"4","key":"54_CR55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ccr.2007.02.016","volume":"11","author":"R Wu","year":"2007","unstructured":"Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash S et al (2007) Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\/beta-catenin and PI3K\/Pten signaling pathways. Cancer Cell 11(4):321\u2013333. doi:10.1016\/j.ccr.2007.02.016","journal-title":"Cancer Cell"},{"issue":"1","key":"54_CR56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1757-2215-3-24","volume":"3","author":"BA Quinn","year":"2010","unstructured":"Quinn BA, Xiao F, Bickel LE, Martin LP, Hua X, Klein-Szanto AJ, Connolly DC (2010) Development of a syngeneic mouse model of epithelial ovarian cancer. J Ovarian Res 3(1):24. doi:10.1186\/1757-2215-3-24","journal-title":"J Ovarian Res"},{"issue":"1","key":"54_CR57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ygyno.2006.07.024","volume":"104","author":"E Jackson","year":"2007","unstructured":"Jackson E, Anderson K, Ashwell C, Petitte J, Mozdziak PE (2007) CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol 104(1):192\u2013198. doi:10.1016\/j.ygyno.2006.07.024","journal-title":"Gynecol Oncol"},{"issue":"1","key":"54_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrm1006","volume":"4","author":"DJ Montell","year":"2003","unstructured":"Montell DJ (2003) Border-cell migration: the race is on. Nat Rev Mol Cell Biol 4(1):13\u201324. doi:10.1038\/nrm1006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"21","key":"54_CR59","doi-asserted-by":"publisher","first-page":"8517","DOI":"10.1158\/0008-5472.CAN-10-1242","volume":"70","author":"CA Hall","year":"2010","unstructured":"Hall CA, Wang R, Miao J, Oliva E, Shen X, Wheeler T, Hilsenbeck SG, Orsulic S, Goode S (2010) Hippo pathway effector yap is an ovarian cancer oncogene. Cancer Res 70(21):8517\u20138525. doi:10.1158\/0008-5472.CAN-10-1242","journal-title":"Cancer Res"},{"issue":"3","key":"54_CR60","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/030098588402100305","volume":"21","author":"RL Gregson","year":"1984","unstructured":"Gregson RL, Lewis DJ, Abbott DP (1984) Spontaneous ovarian neoplasms of the laboratory rat. Vet Pathol 21(3):292\u2013299","journal-title":"Vet Pathol"},{"issue":"5","key":"54_CR61","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"M Shih Ie","year":"2004","unstructured":"Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164(5):1511\u20131518","journal-title":"Am J Pathol"},{"issue":"2","key":"54_CR62","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.AOG.0000227787.24587.d1","volume":"108","author":"DM Gershenson","year":"2006","unstructured":"Gershenson DM, Sun CC, Lu KH, Coleman RL, Sood AK, Malpica A, Deavers MT, Silva EG, Bodurka DC (2006) Clinical behavior of stage II\u2013IV low-grade serous carcinoma of the ovary. Obstet Gynecol 108(2):361\u2013368","journal-title":"Obstet Gynecol"},{"issue":"17","key":"54_CR63","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"RF Ozols","year":"2003","unstructured":"Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R (2003) Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21(17):3194\u20133200","journal-title":"J Clin Oncol"},{"issue":"1","key":"54_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354(1):34\u201343","journal-title":"N Engl J Med"},{"issue":"4","key":"54_CR65","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","volume":"28","author":"A Malpica","year":"2004","unstructured":"Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, Silva EG (2004) Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 28(4):496\u2013504","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"54_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0029-7844(01)01649-0","volume":"99","author":"MA Crispens","year":"2002","unstructured":"Crispens MA, Bodurka D, Deavers M, Lu K, Silva EG, Gershenson DM (2002) Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Obstet Gynecol 99(1):3\u201310","journal-title":"Obstet Gynecol"},{"issue":"7","key":"54_CR67","first-page":"1489","volume":"53","author":"SC Mok","year":"1993","unstructured":"Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS, Tsao SW (1993) Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 53(7):1489\u20131492","journal-title":"Cancer Res"},{"issue":"13","key":"54_CR68","first-page":"3103","volume":"53","author":"MG Teneriello","year":"1993","unstructured":"Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ (1993) p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 53(13):3103\u20133108","journal-title":"Cancer Res"},{"issue":"6","key":"54_CR69","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","volume":"95","author":"G Singer","year":"2003","unstructured":"Singer G, Oldt R 3rd, Cohen Y, Wang BG, Sidransky D, Kurman RJ, Shih Ie M (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 95(6):484\u2013486","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"54_CR70","doi-asserted-by":"publisher","first-page":"9267","DOI":"10.1073\/pnas.89.19.9267","volume":"89","author":"JQ Cheng","year":"1992","unstructured":"Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR (1992) AKT2, a putative oncogene encoding a member of a subfamily of protein-serine\/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA 89(19):9267\u20139271","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"54_CR71","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/ajcp\/111.3.311","volume":"111","author":"JS Ross","year":"1999","unstructured":"Ross JS, Yang F, Kallakury BV, Sheehan CE, Ambros RA, Muraca PJ (1999) HER-2\/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary. Am J Clin Pathol 111(3):311\u2013316","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"54_CR72","first-page":"4460","volume":"9","author":"G Singer","year":"2003","unstructured":"Singer G, Rebmann V, Chen YC, Liu HT, Ali SZ, Reinsberg J, McMaster MT et al (2003) HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 9(12):4460\u20134464","journal-title":"Clin Cancer Res"},{"issue":"18","key":"54_CR73","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/jnci\/85.18.1513","volume":"85","author":"MF Kohler","year":"1993","unstructured":"Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC Jr, Berchuck A (1993) Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst 85(18):1513\u20131519","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"54_CR74","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1073\/pnas.90.11.4961","volume":"90","author":"J Kupryjanczyk","year":"1993","unstructured":"Kupryjanczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, Yandell DW (1993) p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci USA 90(11):4961\u20134965","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"54_CR75","first-page":"117","volume":"13","author":"JS Skilling","year":"1996","unstructured":"Skilling JS, Sood A, Niemann T, Lager DJ, Buller RE (1996) An abundance of p53 null mutations in ovarian carcinoma. Oncogene 13(1):117\u2013123","journal-title":"Oncogene"},{"issue":"3","key":"54_CR76","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ijc.21902","volume":"119","author":"V Ouellet","year":"2006","unstructured":"Ouellet V, Guyot MC, Le Page C, Filali-Mouhim A, Lussier C, Tonin PN, Provencher DM, Mes-Masson AM (2006) Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int J Cancer 119(3):599\u2013607","journal-title":"Int J Cancer"},{"issue":"19","key":"54_CR77","first-page":"4456","volume":"53","author":"MK Dodson","year":"1993","unstructured":"Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC, Jenkins RB (1993) Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res 53(19):4456\u20134460","journal-title":"Cancer Res"},{"issue":"6","key":"54_CR78","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.onc.1208298","volume":"24","author":"I Meinhold-Heerlein","year":"2005","unstructured":"Meinhold-Heerlein I, Bauerschlag D, Hilpert F, Dimitrov P, Sapinoso LM, Orlowska-Volk M, Bauknecht T et al (2005) Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene 24(6):1053\u20131065","journal-title":"Oncogene"},{"issue":"6","key":"54_CR79","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/sj.bjc.6603003","volume":"94","author":"VA Heinzelmann-Schwarz","year":"2006","unstructured":"Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry JP, Scolyer RA, Smith AN, Bali A et al (2006) A distinct molecular profile associated with mucinous epithelial ovarian cancer. Br J Cancer 94(6):904\u2013913","journal-title":"Br J Cancer"},{"issue":"3 Pt 1","key":"54_CR80","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1158\/1078-0432.CCR-05-1110","volume":"12","author":"FW Wamunyokoli","year":"2006","unstructured":"Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C et al (2006) Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin Cancer Res 12(3 Pt 1):690\u2013700","journal-title":"Clin Cancer Res"},{"issue":"4","key":"54_CR81","doi-asserted-by":"publisher","first-page":"e10358","DOI":"10.1371\/journal.pone.0010358","volume":"5","author":"B Pothuri","year":"2010","unstructured":"Pothuri B, Leitao MM, Levine DA, Viale A, Olshen AB, Arroyo C, Bogomolniy F et al (2010) Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS ONE 5(4):e10358. doi:10.1371\/journal.pone.0010358","journal-title":"PLoS ONE"},{"issue":"2","key":"54_CR82","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","volume":"3","author":"CP Crum","year":"2009","unstructured":"Crum CP (2009) Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol 3(2):165\u2013170. doi:10.1016\/j.molonc.2009.01.004","journal-title":"Mol Oncol"},{"issue":"2","key":"54_CR83","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","volume":"31","author":"DW Kindelberger","year":"2007","unstructured":"Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ et al (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31(2):161\u2013169. doi:10.1097\/01.pas.0000213335.40358.47","journal-title":"Am J Surg Pathol"},{"issue":"32","key":"54_CR84","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","volume":"26","author":"K Levanon","year":"2008","unstructured":"Levanon K, Crum C, Drapkin R (2008) New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 26(32):5284\u20135293. doi:10.1200\/JCO.2008.18.1107","journal-title":"J Clin Oncol"},{"issue":"10","key":"54_CR85","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","volume":"34","author":"CG Przybycin","year":"2010","unstructured":"Przybycin CG, Kurman RJ, Ronnett BM, Shih Ie M, Vang R (2010) Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34(10):1407\u20131416. doi:10.1097\/PAS.0b013e3181ef7b16","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"54_CR86","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370","journal-title":"Cell"},{"issue":"17","key":"54_CR87","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.1158\/0008-5472.CAN-06-1410","volume":"66","author":"LY Han","year":"2006","unstructured":"Han LY, Landen CN, JGHalder Trevino J, Lin YG, Kamat AA, Kim TJ, Merritt WM et al (2006) Anti-angiogenic and anti-tumor effects of Src inhibition in ovarian carcinoma. Cancer Res 66(17):8633\u20138639","journal-title":"Cancer Res"},{"issue":"3","key":"54_CR88","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ccr.2004.09.001","volume":"6","author":"R Ishizawar","year":"2004","unstructured":"Ishizawar R, Parsons SJ (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6(3):209\u2013214","journal-title":"Cancer Cell"},{"issue":"48","key":"54_CR89","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1038\/sj.onc.1208159","volume":"23","author":"CM Silva","year":"2004","unstructured":"Silva CM (2004) Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23(48):8017\u20138023","journal-title":"Oncogene"},{"issue":"2","key":"54_CR90","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.bbrc.2003.08.012","volume":"309","author":"Y Pengetnze","year":"2003","unstructured":"Pengetnze Y, Steed M, Roby KF, Terranova PF, Taylor CC (2003) Src tyrosine kinase promotes survival and resistance to chemotherapeutics in a mouse ovarian cancer cell line. Biochem Biophys Res Commun 309(2):377\u2013383","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"54_CR91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/gyno.2002.6851","volume":"88","author":"JR Wiener","year":"2003","unstructured":"Wiener JR, Windham TC, Estrella VC, Parikh NU, Thall PF, Deavers MT, Bast RC, Mills GB, Gallick GE (2003) Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. Gynecol Oncol 88(1):73\u201379","journal-title":"Gynecol Oncol"},{"issue":"3","key":"54_CR92","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/bjc.1996.53","volume":"73","author":"JM Bartlett","year":"1996","unstructured":"Bartlett JM, Langdon SP, Simpson BJ, Stewart M, Katsaros D, Sismondi P, Love S et al (1996) The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer 73(3):301\u2013306","journal-title":"Br J Cancer"},{"issue":"6","key":"54_CR93","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1525-1438.1992.02060291.x","volume":"2","author":"JA Leary","year":"1992","unstructured":"Leary JA, Edwards BG, Houghton CR, Kefford RF, Friedlander ML (1992) Amplification of HER-2\/neu oncogene in human ovarian cancer. Int J Gynecol Cancer 2(6):291\u2013294","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"54_CR94","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0165-4608(99)00192-2","volume":"118","author":"M Suzuki","year":"2000","unstructured":"Suzuki M, Saito S, Saga Y, Ohwada M, Sato I (2000) Mutation of K-RAS protooncogene and loss of heterozygosity on 6q27 in serous and mucinous ovarian carcinomas. Cancer Genet Cytogenet 118(2):132\u2013135","journal-title":"Cancer Genet Cytogenet"},{"key":"54_CR95","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2353\/ajpath.2010.100212","volume":"177","author":"KK Wong","year":"2010","unstructured":"Wong KK, Tsang YT, Deavers MT, Mok SC, Zu Z, Sun C, Malpica A, Wolf JK, Lu KH, Gershenson DM (2010) BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas. Am J Pathol 177:1611\u20131617. doi:10.2353\/ajpath.2010.100212","journal-title":"Am J Pathol"},{"issue":"1","key":"54_CR96","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/gyno.2001.6308","volume":"83","author":"L Sui","year":"2001","unstructured":"Sui L, Dong Y, Ohno M, Sugimoto K, Tai Y, Hando T, Tokuda M (2001) Implication of malignancy and prognosis of p27(kip1), cyclin E, and Cdk2 expression in epithelial ovarian tumors. Gynecol Oncol 83(1):56\u201363","journal-title":"Gynecol Oncol"},{"issue":"7","key":"54_CR97","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/sj.bjc.6690826","volume":"81","author":"KK Dhar","year":"1999","unstructured":"Dhar KK, Branigan K, Parkes J, Howells RE, Hand P, Musgrove C, Strange RC, Fryer AA, Redman CW, Hoban PR (1999) Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells. Br J Cancer 81(7):1174\u20131181","journal-title":"Br J Cancer"},{"issue":"10","key":"54_CR98","doi-asserted-by":"publisher","first-page":"925","DOI":"10.4065\/72.10.925","volume":"72","author":"BA Barrette","year":"1997","unstructured":"Barrette BA, Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Podratz KC, Roche PC (1997) Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc 72(10):925\u2013929","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"54_CR99","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jnci\/94.7.522","volume":"94","author":"R Bao","year":"2002","unstructured":"Bao R, Connolly DC, Murphy M, Green J, Weinstein JK, Pisarcik DA, Hamilton TC (2002) Activation of cancer-specific gene expression by the survivin promoter. J Natl Cancer Inst 94(7):522\u2013528","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"54_CR100","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1073\/pnas.96.1.214","volume":"96","author":"Y Yu","year":"1999","unstructured":"Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B et al (1999) NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA 96(1):214\u2013219","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"54_CR101","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jcb.240450108","volume":"45","author":"D Michalovitz","year":"1991","unstructured":"Michalovitz D, Halevy O, Oren M (1991) p53 mutations: gains or losses? J Cell Biochem 45(1):22\u201329","journal-title":"J Cell Biochem"},{"key":"54_CR102","doi-asserted-by":"publisher","unstructured":"Cheng JC, Auersperg N, Leung PC (2010) Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K\/Akt-mediated suppression of E-cadherin. Oncogene. doi:10.1038\/onc.2010.486","DOI":"10.1038\/onc.2010.486"},{"issue":"1","key":"54_CR103","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/gyno.1996.0014","volume":"60","author":"JS Skilling","year":"1996","unstructured":"Skilling JS, Squatrito RC, Connor JP, Niemann T, Buller RE (1996) p53 gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines. Gynecol Oncol 60(1):72\u201380","journal-title":"Gynecol Oncol"},{"issue":"11","key":"54_CR104","first-page":"2979","volume":"51","author":"JR Marks","year":"1991","unstructured":"Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC Jr, Berchuck A (1991) Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51(11):2979\u20132984","journal-title":"Cancer Res"},{"issue":"2","key":"54_CR105","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ygyno.2005.06.041","volume":"99","author":"R Kerner","year":"2005","unstructured":"Kerner R, Sabo E, Gershoni-Baruch R, Beck D, Ben-Izhak O (2005) Expression of cell cycle regulatory proteins in ovaries prophylactically removed from Jewish Ashkenazi BRCA1 and BRCA2 mutation carriers: correlation with histopathology. Gynecol Oncol 99(2):367\u2013375","journal-title":"Gynecol Oncol"},{"issue":"4","key":"54_CR106","first-page":"1087","volume":"62","author":"L Hu","year":"2002","unstructured":"Hu L, Hofmann J, Lu Y, Mills GB, Jaffe RB (2002) Inhibition of phosphatidylinositol 3\u2032-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res 62(4):1087\u20131092","journal-title":"Cancer Res"},{"issue":"14","key":"54_CR107","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/onc.2009.4","volume":"28","author":"D Reisman","year":"2009","unstructured":"Reisman D, Glaros S, Thompson EA (2009) The SWI\/SNF complex and cancer. Oncogene 28(14):1653\u20131668. doi:10.1038\/onc.2009.4","journal-title":"Oncogene"},{"issue":"16","key":"54_CR108","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","volume":"363","author":"KC Wiegand","year":"2010","unstructured":"Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J et al (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363(16):1532\u20131543. doi:10.1056\/NEJMoa1008433","journal-title":"N Engl J Med"},{"issue":"5\u20136","key":"54_CR109","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0006-2952(02)01151-6","volume":"64","author":"V Deregowski","year":"2002","unstructured":"Deregowski V, Delhalle S, Benoit V, Bours V, Merville MP (2002) Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells. Biochem Pharmacol 64(5\u20136):873\u2013881","journal-title":"Biochem Pharmacol"},{"issue":"19","key":"54_CR110","first-page":"5334","volume":"60","author":"S Huang","year":"2000","unstructured":"Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ (2000) Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60(19):5334\u20135339","journal-title":"Cancer Res"},{"issue":"6","key":"54_CR111","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","volume":"34","author":"E Kuhn","year":"2010","unstructured":"Kuhn E, Meeker A, Wang TL, Sehdev AS, Kurman RJ, Shih Ie M (2010) Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol 34(6):829\u2013836. doi:10.1097\/PAS.0b013e3181dcede7","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"54_CR112","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4161\/cbt.3.12.1235","volume":"3","author":"CN Landen","year":"2004","unstructured":"Landen CN, Klingelhutz A, Coffin JE, Sorosky JI, Sood AK (2004) Genomic instability is associated with lack of telomerase activation in ovarian cancer. Cancer Biol Ther 3(12):1250\u20131253","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"54_CR113","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/path.1191","volume":"198","author":"C Poremba","year":"2002","unstructured":"Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer KL, Braun Y et al (2002) Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Pathol 198(2):181\u2013189","journal-title":"J Pathol"},{"issue":"1","key":"54_CR114","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/carcin\/bgl115","volume":"28","author":"G Yang","year":"2007","unstructured":"Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast RC Jr, Zhou C, Liu J (2007) Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Carcinogenesis 28(1):174\u2013182","journal-title":"Carcinogenesis"},{"issue":"1","key":"54_CR115","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0006-291X(03)00318-8","volume":"303","author":"C Zhou","year":"2003","unstructured":"Zhou C, Liu J (2003) Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells. Biochem Biophys Res Commun 303(1):130\u2013136","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"54_CR116","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869\u201310874","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"54_CR117","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1158\/1078-0432.CCR-04-2548","volume":"11","author":"E Wang","year":"2005","unstructured":"Wang E, Ngalame Y, Panelli MC, Nguyen-Jackson H, Deavers M, Mueller P, Hu W et al (2005) Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer. Clin Cancer Res 11(1):113\u2013122","journal-title":"Clin Cancer Res"},{"issue":"1","key":"54_CR118","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1(1):27\u201331","journal-title":"Nat Med"},{"issue":"2","key":"54_CR119","first-page":"65","volume":"3","author":"J Folkman","year":"1992","unstructured":"Folkman J (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol 3(2):65\u201371","journal-title":"Semin Cancer Biol"},{"key":"54_CR120","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ygyno.2006.10.062","volume":"104","author":"M Frumovitz","year":"2007","unstructured":"Frumovitz M, Sood AK (2007) Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies. Gynecol Oncol 104:768\u2013778","journal-title":"Gynecol Oncol"},{"issue":"5","key":"54_CR121","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1172\/JCI114322","volume":"84","author":"DT Connolly","year":"1989","unstructured":"Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84(5):1470\u20131478","journal-title":"J Clin Invest"},{"issue":"4587","key":"54_CR122","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1126\/science.6823562","volume":"219","author":"DR Senger","year":"1983","unstructured":"Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219(4587):983\u2013985","journal-title":"Science"},{"issue":"6","key":"54_CR123","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/jnci\/90.6.447","volume":"90","author":"J Yoneda","year":"1998","unstructured":"Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ (1998) Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst 90(6):447\u2013454","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"54_CR124","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A","volume":"80","author":"PJ Paley","year":"1997","unstructured":"Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF, Ramakrishnan S (1997) Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80(1):98\u2013106","journal-title":"Cancer"},{"issue":"10","key":"54_CR125","first-page":"3193","volume":"8","author":"BC Cooper","year":"2002","unstructured":"Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ, Sood AK (2002) Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Clin Cancer Res 8(10):3193\u20133197","journal-title":"Clin Cancer Res"},{"issue":"2","key":"54_CR126","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ygyno.2005.12.011","volume":"102","author":"AE Lokshin","year":"2006","unstructured":"Lokshin AE, Winans M, Landsittel D, Marrangoni AM, Velikokhatnaya L, Modugno F, Nolen BM, Gorelik E (2006) Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecol Oncol 102(2):244\u2013251","journal-title":"Gynecol Oncol"},{"issue":"2","key":"54_CR127","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3727\/096504001108747567","volume":"12","author":"L Xu","year":"2000","unstructured":"Xu L, Fidler IJ (2000) Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol Res 12(2):97\u2013106","journal-title":"Oncol Res"},{"issue":"2","key":"54_CR128","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0090-8258(03)00321-4","volume":"90","author":"B Davidson","year":"2003","unstructured":"Davidson B, Goldberg I, Reich R, Tell L, Dong HP, Trope CG, Risberg B, Kopolovic J (2003) AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients. Gynecol Oncol 90(2):248\u2013257","journal-title":"Gynecol Oncol"},{"issue":"15","key":"54_CR129","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1158\/1078-0432.CCR-03-0589","volume":"10","author":"PH Thaker","year":"2004","unstructured":"Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK (2004) EphA2 expression is associated with aggressive features in ovarian carcinoma. Clin Cancer Res 10(15):5145\u20135150","journal-title":"Clin Cancer Res"},{"issue":"15","key":"54_CR130","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","volume":"65","author":"CN Landen Jr","year":"2005","unstructured":"Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK (2005) Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 65(15):6910\u20136918","journal-title":"Cancer Res"},{"issue":"21","key":"54_CR131","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/jnci\/djj414","volume":"98","author":"CN Landen Jr","year":"2006","unstructured":"Landen CN Jr, Lu C, Han LY, Coffman KT, Bruckheimer E, Halder J, Mangala LS et al (2006) Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. J Natl Cancer Inst 98(21):1558\u20131570","journal-title":"J Natl Cancer Inst"},{"issue":"1\u20132","key":"54_CR132","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1023\/A:1026510130114","volume":"19","author":"YD Jung","year":"2000","unstructured":"Jung YD, Ahmad SA, Akagi Y, Takahashi Y, Liu W, Reinmuth N, Shaheen RM, Fan F, Ellis LM (2000) Role of the tumor microenvironment in mediating response to anti-angiogenic therapy. Cancer Metastasis Rev 19(1\u20132):147\u2013157","journal-title":"Cancer Metastasis Rev"},{"issue":"17","key":"54_CR133","first-page":"5224","volume":"63","author":"D Belotti","year":"2003","unstructured":"Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G, Giavazzi R (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63(17):5224\u20135229","journal-title":"Cancer Res"},{"issue":"1","key":"54_CR134","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ijc.2910580110","volume":"58","author":"MS Naylor","year":"1994","unstructured":"Naylor MS, Stamp GW, Davies BD, Balkwill FR (1994) Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 58(1):50\u201356","journal-title":"Int J Cancer"},{"issue":"1","key":"54_CR135","first-page":"5","volume":"20","author":"CA Herrera","year":"2002","unstructured":"Herrera CA, Xu L, Bucana CD, el Silva VG, Hess KR, Gershenson DM, Fidler IJ (2002) Expression of metastasis-related genes in human epithelial ovarian tumors. Int J Oncol 20(1):5\u201313","journal-title":"Int J Oncol"},{"issue":"15","key":"54_CR136","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/94.15.1134","volume":"94","author":"S Huang","year":"2002","unstructured":"Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, Fidler IJ (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94(15):1134\u20131142","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"54_CR137","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB et al (2006) Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12(8):939\u2013944","journal-title":"Nat Med"},{"issue":"3","key":"54_CR138","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nrc1820","volume":"6","author":"MH Antoni","year":"2006","unstructured":"Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, Stefanek M, Sood AK (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6(3):240\u2013248","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"54_CR139","first-page":"53","volume":"21","author":"H Ben-Hur","year":"2000","unstructured":"Ben-Hur H, Gurevich P, Huszar M, Ben-Arie A, Berman V, Tendler Y, Zinder O et al (2000) Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors. Eur J Gynaecol Oncol 21(1):53\u201357","journal-title":"Eur J Gynaecol Oncol"},{"issue":"8","key":"54_CR140","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1073\/pnas.95.8.4510","volume":"95","author":"P Paul","year":"1998","unstructured":"Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95(8):4510\u20134515","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"54_CR141","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/jemt.20307","volume":"69","author":"A Bukovsky","year":"2006","unstructured":"Bukovsky A (2006) Immune system involvement in the regulation of ovarian function and augmentation of cancer. Microsc Res Tech 69(6):482\u2013500","journal-title":"Microsc Res Tech"},{"issue":"1","key":"54_CR142","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1677\/erc.0.0060093","volume":"6","author":"MA Nash","year":"1999","unstructured":"Nash MA, Ferrandina G, Gordinier M, Loercher A, Freedman RS (1999) The role of cytokines in both the normal and malignant ovary. Endocr-Relat Cancer 6(1):93\u2013107","journal-title":"Endocr-Relat Cancer"},{"issue":"3","key":"54_CR143","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348(3):203\u2013213","journal-title":"N Engl J Med"},{"issue":"9","key":"54_CR144","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1517\/14712598.5.9.1193","volume":"5","author":"G Coukos","year":"2005","unstructured":"Coukos G, Conejo-Garcia JR, Roden RB, Wu TC (2005) Immunotherapy for gynaecological malignancies. Expert Opin Biol Ther 5(9):1193\u20131210","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"54_CR145","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ (2003) The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer 3(6):453\u2013458","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"54_CR146","first-page":"74","volume":"68","author":"J Emerich","year":"1997","unstructured":"Emerich J, Konefka T, Dudziak M, Sobol A (1997) The value of peritoneal cytology in the staging of ovarian cancer. Ginekol Pol 68(2):74\u201377","journal-title":"Ginekol Pol"},{"issue":"2","key":"54_CR147","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrc727","volume":"2","author":"JD Hood","year":"2002","unstructured":"Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2(2):91\u2013100","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"54_CR148","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<285::AID-IJC19>3.0.CO;2-L","volume":"80","author":"F Carreiras","year":"1999","unstructured":"Carreiras F, Rigot V, Cruet S, Andre F, Gauduchon P, Marvaldi J (1999) Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of alpha(v)beta3 integrins and vitronectin. Int J Cancer 80(2):285\u2013294","journal-title":"Int J Cancer"},{"issue":"1\u20132","key":"54_CR149","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(03)00068-6","volume":"202","author":"K Sundfeldt","year":"2003","unstructured":"Sundfeldt K (2003) Cell\u2013cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule. Mol Cell Endocrinol 202(1\u20132):89\u201396","journal-title":"Mol Cell Endocrinol"},{"issue":"16","key":"54_CR150","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1158\/1078-0432.CCR-06-0021","volume":"12","author":"J Halder","year":"2006","unstructured":"Halder J, Kamat AA, Landen CN Jr, Han LY, Lutgendorf SK, Lin YG, Merritt WM et al (2006) Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res 12(16):4916\u20134924","journal-title":"Clin Cancer Res"},{"issue":"3","key":"54_CR151","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.0.CO;2-W","volume":"74","author":"K Sundfeldt","year":"1997","unstructured":"Sundfeldt K, Piontkewitz Y, Ivarsson K, Nilsson O, Hellberg P, Brannstrom M, Janson PO, Enerback S, Hedin L (1997) E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int J Cancer 74(3):275\u2013280","journal-title":"Int J Cancer"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-010-0054-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-010-0054-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-010-0054-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-010-0054-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T17:14:10Z","timestamp":1609262050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-010-0054-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,30]]},"references-count":151,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["54"],"URL":"https:\/\/doi.org\/10.1007\/s12672-010-0054-2","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,30]]},"assertion":[{"value":"30 November 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}